Marketresearchnews

Global Digital Wound Measurement Devices Market Set For Big Growth - Foresight By 2023

Market Scenario

The global digital wound measurement devices market is expected to witness a positive growth during the forecast period. Digital wound measurement devices enable monitoring of chronic wounds and deliver the appropriate drug dose to speed up the process of healing. Chronic wounds if not treated on time can lead to severe infections and amputations. Hence, digital wound measurement devices allow delivering tailored treatments after the 2D or 3D assessment of the infection and inflammation. The increasing number of patients suffering from chronic wounds drives the market growth. According to the Intermountain Healthcare (2017), 6.5 million people in the US suffer from chronic wounds. Diabetic wounds are severe, and the process of healing is very long and eventually may lead to amputations. Hence factors such as growing diabetic patients, rising geriatric population, and an increasing number of surgeries are major factors influencing the growth of the market. The emergence of smartphones, rapid use of advanced digital tools, and the advent of telehealth for wound care will also contribute for the market to grow.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6289

However, factors such as, the inability of the device to provide additional information about wounds such as moistness or exudation and high costs of digital devices are expected to restrict the market growth during the forecast period.

Key Players

WoundRight Technologies Tissue Analytics
Parable Health
ARANZ Medical Limited
eKare, Inc,
KCI,
an Acelity Company,
WoundMatrix, Inc.,
WoundZoom Inc.,
Kent Imaging Inc.,
WoundRight Technologies, LLC,
WoundVision, LLC,
Hitachi Healthcare Americas,
Smith & Nephew plc.

Segmentation

The global digital wound measurement devices market is segmented on the basis of wound type, product, and end-user. The digital wound measurement devices market, by wound type is sub-segmented into a diabetic ulcer, chronic wounds, burns, incisional, and traumatic. The product segment is sub-segmented into contact wound measuring devices and non-contact wound measuring devices.

On the basis of end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.

On the basis of region, the global digital wound measurement devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Regional Market

Asia-Pacific was projected to be the fastest growing region for the global digital wound measurement devices market demand. Key factors such as rising geriatric population, growing diabetic patient pool, high incidence chronic wounds, and developing healthcare infrastructure drive the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world diabetic population is in Asia. This provides favorable backgrounds for the market to grow in Asia.

The digital wound measurement devices market is dominated by North America owing to the rising prevalence of chronic wounds and technological advancements in the healthcare sector. In June 2018, KCI, an Acelity Company announced the launch of Nurse2Nurse (N2N) Mobile App for wound care nurses. The app allows interactions with clinicians and shares credible insights and information for better patient care.

It is estimated that Europe was the second largest in the global digital wound measurement devices market. The increasing technological advancement and research for wound care along with government support in Europe drive the market growth in this region. The European Wound Management Association will conduct its 29th conference by June 2019 in Gothenburg, Sweden in the presence of several international wound management communities with the common goal of improving the care of wound patients.

The Middle East and Africa holds the least share of the global digital wound measurement devices market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investments by private market players in this region can boost the market growth.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-wound-measurement-devices-market-6289

See More Topic Related Videos @:

Colposcopy Market 2023 – Market Size, Share, Trends Analysis And Growth Forecast

Market Scenario

A colposcope is basically a surgical instrument similar to an electric microscope with a source of light that allows gynecologists to examine the vagina and cervix more clearly and under proper magnification. The rising prevalence of cervical cancer around the globe is the primary factor driving the growth of the colposcopy market.

For instance, according to the World Health Organization (WHO) in 2017, cervical cancer is the second most reason for the death of women worldwide. Currently, awareness programmes are conducted by numerous NGOs focusing on health-related issues in women such as cervical cancer which will increase the demand for colposcopes.

The upcoming Global Colposcopy Market trends is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global colposcopy market is expected to register a CAGR of ~6.8% during the forecast period, 2018–2023.

Despite these drivers, factors such as high installation cost of this device and lack of skilled clinical users to operate colposcopes are likely to restrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6273

Company Profiles

Carl Zeiss
Olympus Corporation
Danaher Corporation
Philips Healthcare
CooperSurgical
McKesson Corporation
DYSIS Medical
Atmos
Alliton
Seliga Microscopes
Karl Kaps
Bovie Medical

Segmentation

The global colposcopy market is segmented on the basis of instrument type, instrument portability, application, and end-users.

On the basis of instrument type, the market is classified into optical colposcopes and digital colposcopes.

On the basis of instrument portability, the market is classified into portable, fixed, and handheld.

On the basis of application, the market is classified as cervical cancer screening, physical examinations, and others.

On the basis of magnification type, the market is classified into fixed magnification and variable magnification

On the basis of end-user, the market is classified into hospitals, clinics, diagnostic centers, and others.

Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American colposcopy market is further segmented into North America and South America. North America is further classified as the US and Canada.

The European colposcopy market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.

The colposcopy market in Asia-Pacific is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific.

The Middle Eastern and African colposcopy market is segmented into the Middle East and Africa.

Regional Market Summary

Asia-Pacific is the fastest growing region in the market owing to the increasing cases of cervical cancer in the region, growing demand for cervical cancer screening, and rising healthcare expenditure in Asian countries. Additionally, according to a study published in the World Health Organization (WHO) in 2017, every year cervical cancer kills more than 250000 women, and 85% of these deaths occur in low- and middle-income countries. Furthermore, the rapid development of economies and increasing healthcare expenditure have fuelled the growth of the market.

The Americas is likely to dominate the global colposcopy market owing to technological advancements in colposcopes such as high-quality video and improved accuracy in detection. For instance, the American Cancer Society in 2018, estimated about 13,240 new cases of invasive cervical cancer to be diagnosed in the US with nearly 4,170 women dying from cervical cancer. Furthermore, continuous development of advanced colposcopy by manufacturers in the region contributes to the market growth.

Europe is likely to hold the second position in the global colposcopy market. It is expected that the favorable reimbursement scenario is responsible for the ambient growth in this region. Additionally, according to the Cancer Research UK in 2017, more than 3000 new cases of cervical cancer are diagnosed in the UK each year.

The Middle East and Africa accounts for the lowest market share in the global colposcopy market owing to the lack of awareness regarding cervical cancer in the MEA region.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/colposcopy-market-6273

See More Topic Related Videos @:

Global Distraction Osteogenesis Devices Market Set For Big Growth - Foresight By 2023

Market Scenario:

Global Distraction Osteogenesis Devices Market Insights asserts, the market is expected to grow significantly over the forecast period. Distraction osteogenesis is the biological process of the new bone formation between bone segments which are gradually separated by incremental traction.

Numerous factors such as advancements in distractor devices such as miniaturized internal and external devices, easily placeable and easy handling are expected to drive the growth of the market. For instance, In May 2018, DePuy Synthes, a part of the Johnson & Johnson Medical Devices Companies, announced an exclusive agreement in the US between DePuy Synthes Sales, Inc. and Prosidyan to promote the Fibergraft family of products, a line of synthetic bone graft materials which are ultra-porous, designed for ease of use, and have been engineered for ideal resorption in clinical use during spine fusion surgery. By adding Fibergraft to its offerings, DePuy Synthes will further enhance the company’s portfolio of biomaterials and distractors.

Moreover, various risks such as failure to follow the distraction protocol and damages to nerves hamper the market growth during the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6392

Key players

Johnson & Johnson Services, Inc., Zimmer Biomet Holdings, Inc., Stryker Corporation, KLS Martin Group, Osteomed, Acumed LLC, Jeil Medical Corporation, Ningbo Cibei Medical Treatment Appliance Co., Ltd. Ortho Max Manufacturing Company Pvt. Ltd., Ortho Care and Titamed are some of the key players in the global distraction osteogenesis devices market.

Segmentation

The Global Distraction Osteogenesis Devices Market has been segmented into device type, age, application, and end-user.

The market, based on device type, has been segmented into mandibular distraction devices, palatal distraction devices, alveolar distraction devices, craniofacial distraction devices, Lefort distraction devices, small bone distraction devices, and others. The market, based on craniofacial distraction devices, has been further segmented into external and internal distractors. The market, based on external distractors is further classified into unidirectional distractors, bidirectional distractors, and multiplanar distractors whereas the market, based on, internal distractors can be classified into tooth-borne distractors, bone-borne distractors, and hybrid distractors. The market, by age, has been segmented into pediatrics and adults. The market, by application, has been segmented into dentistry, podiatry, orthopedics, and others. The market, by end-user, has been segmented into hospitals, orthopedic clinics, and others.

Regional Market Summary

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Distraction Osteogenesis Devices Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European distraction osteogenesis devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The Distraction Osteogenesis Devices Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The distraction osteogenesis devices market in the Middle East & Africa has been segmented into the Middle East and Africa.

Geographically, North America is expected to dominate the global distraction osteogenesis devices market owing to increasing number of procedures for treating facial abnormalities in the US. Also, most of the key players have their research and development teams working in this field in the US which in turn increases the awareness among the people about the technique in this region.

The European market is expected to be the second-largest due to increase in initiatives taken by public and private organizations in this field.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/distraction-osteogenesis-devices-market-6392

See More Topic Related Videos @:

Verrucous Carcinoma Market Forecasts By Industry Drivers, Regions Till 2023

Market Insights

Verrucous Carcinoma typically debuts as an anomalous growth or as alteration in the constancy of an earlier potentially malignant ailment of the oral cavity. Verrucous Carcinoma is a rare, locally aggressive, clinically exophytic, low-grade, slow-growing, well-differentiated squamous cell carcinoma with nominal metastatic potential. It is unusual subtype of malignant ailment which affects oral cavity. Verrucous Carcinoma can affect all mucosal sites of the oral cavity. However, the frequency of malignant transformation of a leukoplakia to an OVC is considerably higher if they are in the gums in comparison to the tongue.

Verrucous Carcinoma is mainly caused by the snuffing of tobacco or chewing of tobacco. It is also referred to as snuff dipper's cancer. Verrucous Carcinoma mostly prevails at oral zones. The condition common in males within the age group 50 to 80 years. The increasing incidences of oral cancer primarily influences the market. Lifestyle factors such as smoking marijuana or tobacco and alcohol consumption mostly drives the Verrucous Carcinoma market. Additionally, growing consumption of alcohol, increasing adoption of sedentary lifestyle, increasing rates of sexually transmitted viruses by human papillomavirus, and family history of cancer prevalence contribute largely towards the development of the market. In 2015, the World Health Organization reported that 1.1 billion people smoked tobacco globally. This is likely to accelerate the market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6367

However, the high cost of surgical procedures, side effects associated with treatments, and expensive chemotherapy treatments are anticipated to limit the market growth to a certain extent.

Market Segmentation

The worldwide Verrucous Carcinoma market has been segmented based on treatment, end-user, and diagnosis.

Based on treatment, the Verrucous Carcinoma market has been segmented into radiation therapy, surgery, targeted drug therapy, and chemotherapy. Surgery has been sub-segmented into Mohs micrographic surgery and surgical excision. Chemotherapy has been sub-segmented into 5-fluorouracil, bleomycin, methotrexate, cisplatin, and others. Based on end-user, the Verrucous Carcinoma market has been segmented into ambulatory surgical centers, hospitals and clinics, research centers, diagnostic centers, and others. Based on diagnosis, the Verrucous Carcinoma market has been segmented into endoscopy, imaging tests, and biopsy. Imaging tests have been sub-segmented into magnetic resonance imaging, positron emission tomography scans, and computerized tomography scans.

Regional Analysis

The Americas represent the largest Verrucous Carcinoma market share in the global market. The market growth is owing to the increasing healthcare expenditure and surging prevalence of Human Papillomavirus (HPV). As recorded by the Genital HPV Infection, Fact Sheet 2017, 79 million American adults were infested with HPV. Europe (Belgium, UK, Netherlands, and France) represents the second largest Verrucous Carcinoma market over the forecast period. Rising prevalence of head and neck cancer drives the Verrucous Carcinoma market in this region. The Cancer Research UK revealed that in 2015, there were12061 new instances of neck and head cancer. These statistics substantially drive the Verrucous Carcinoma market in Europe.

In 2017, Asia-Pacific was estimated to be the fastest growing region for the worldwide Verrucous Carcinoma market. The market has been expected to develop owing to the rising addiction to smoking. According to the World Health Organization, in 2015, 33.7% and 47.6% of people smoked tobacco in Japan and China, respectively. The Middle East and Africa holds the least market share due to lack of availability of trained healthcare professionals and low per capita income in the region. Nevertheless, the growing palliative and oncology care services both at the community and the hospital level are expected to influence the market positively.

Key Players

The global Verrucous Carcinoma market is dominated by key players such as Qilu Pharmaceutical Co., Ltd. (Asia Pacific), Bristol-Myers Squibb Company (US), Eli Lilly and Company. (US), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Europe), Pfizer Inc. (US), Novartis AG (Europe), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/verrucous-carcinoma-market-6367

See More Topic Related Videos @: